Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
91.08 USD | -2.44% | +2.38% | -13.84% |
06:56pm | TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating | MT |
05:59pm | BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.84% | 22.5B | |
+9.55% | 106B | |
+1.01% | 104B | |
+6.72% | 23.25B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-11.34% | 16.99B | |
+8.28% | 14.26B | |
+38.57% | 12.76B | |
+328.80% | 8.62B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech : Plans First mRNA Malaria Vaccine, to Evaluate 'Multiple' Candidates